C WorldWide Group Holding A S Has $3.68 Million Stake in Amdocs Limited $DOX

C WorldWide Group Holding A S boosted its holdings in Amdocs Limited (NASDAQ:DOX) by 101.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,896 shares of the technology company’s stock after buying an additional 22,618 shares during the period. C WorldWide Group Holding A S’s holdings in Amdocs were worth $3,684,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Bessemer Group Inc. lifted its stake in shares of Amdocs by 354.6% in the 3rd quarter. Bessemer Group Inc. now owns 1,332 shares of the technology company’s stock valued at $109,000 after purchasing an additional 1,039 shares during the period. Gallacher Capital Management LLC bought a new stake in Amdocs in the third quarter valued at about $694,000. Ashton Thomas Private Wealth LLC lifted its stake in Amdocs by 226.9% in the third quarter. Ashton Thomas Private Wealth LLC now owns 76,084 shares of the technology company’s stock valued at $6,283,000 after buying an additional 52,810 shares during the period. Penserra Capital Management LLC boosted its holdings in Amdocs by 23.6% during the third quarter. Penserra Capital Management LLC now owns 123,431 shares of the technology company’s stock worth $10,127,000 after buying an additional 23,550 shares during the last quarter. Finally, Running Oak Capital LLC boosted its holdings in Amdocs by 4.6% during the third quarter. Running Oak Capital LLC now owns 183,194 shares of the technology company’s stock worth $15,084,000 after buying an additional 8,071 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Wall Street Analysts Forecast Growth

DOX has been the subject of a number of recent analyst reports. Bank of America lowered their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday. Stifel Nicolaus reduced their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Finally, Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Q1 results beat consensus: Amdocs reported Q1 FY2026 EPS and revenue slightly above estimates with revenue up year‑over‑year, and management highlighted growth initiatives (including telco AI work and a T‑Mobile deal) that support longer‑term revenue expansion. Q1 beat article
• Positive Sentiment: Dividend hike: Amdocs raised its quarterly dividend ~8% to $0.569, lifting the yield to roughly 3.1%, which supports income investors and signals board confidence in cash flow. (Company announcement)
• Neutral Sentiment: Analyst action — Stifel keeps a Buy rating but trims the price target (from $97 to $88). That reflects continued analyst conviction in the business while acknowledging nearer‑term headwinds. Stifel note
• Neutral Sentiment: CEO succession announced: Long‑time CEO Shuky Sheffer will retire March 31; Shimie Hortig is named successor. Leadership transition introduces execution risk but also a clear succession plan. CEO appointment
• Negative Sentiment: Guidance / outlook reaction: Management’s forward commentary and updated 2026 outlook prompted a sharper market reaction than the quarter itself — investors sold into the mixed print because near‑term guidance cadence and margin/booking details were viewed as disappointing. Guidance reaction
• Negative Sentiment: Price action and downside momentum: Coverage noted the stock hitting a new 12‑month low after the post‑earnings move, signaling short‑term bearish momentum and higher volatility risk for holders. 12‑month low report
• Neutral Sentiment: Analyst / media takeaways: Several writeups emphasize “the good and the bad” — beat and strategic initiatives vs. near‑term guidance/leadership transition — leaving the setup as a classic tradeoff between near‑term risk and longer‑term catalysts. Seeking Alpha analysis

Amdocs Stock Performance

Shares of DOX opened at $71.13 on Friday. The firm has a market cap of $7.68 billion, a P/E ratio of 13.76, a PEG ratio of 1.24 and a beta of 0.40. Amdocs Limited has a twelve month low of $70.24 and a twelve month high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.17 and a current ratio of 1.17. The firm’s 50 day moving average price is $80.21 and its two-hundred day moving average price is $82.49.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.13%. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period last year, the business posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. The ex-dividend date is Tuesday, March 31st. This is a boost from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.2%. Amdocs’s dividend payout ratio is 40.81%.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.